PVT1 was upregulated, and its target, miR-190a-5p, was downregulated in CHF patients. Although the both could become independent diagnostic biomarkers of CHF, the combination of PVT1 and miR-150a-5p showed better diagnostic accuracy. The gene discussed is PVT1; the disease is congestive heart failure.